Literature DB >> 13289212

Studies on respiratory rate in the newborn; its use in the evaluation of respiratory distress in infants of diabetic mothers.

H M HADDAD, D Y Y HSIA, S S GELLIS.   

Abstract

Entities:  

Keywords:  INFANT, NEWBORN/physiology; RESPIRATION/physiology

Mesh：

Year:  1956        PMID： 13289212

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  8 in total

1.  Certain manifestations of respiration in prematurity.

Authors:  K G PHILLIPS
Journal:  Can Med Assoc J       Date:  1961-07-29       Impact factor: 8.262

2.  Factors affecting the prognosis for survival in prematurely born infants.

Authors:  K G PHILLIPS; J G ARMSTRONG; B G DELTA
Journal:  Can Med Assoc J       Date:  1959-05-15       Impact factor: 8.262

Review 3.  Postnatal steroid treatment and brain development.

Authors:  O Baud
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-03       Impact factor: 5.747

Review 4.  Management of bronchopulmonary dysplasia in infants: guidelines for corticosteroid use.

Authors:  David G Grier; Henry L Halliday
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Prevention of hyaline membrane disease.

Authors: 
Journal:  Br Med J       Date:  1973-04-14

6.  [Specific glucocorticoid receptor activity in the lungs and concentration of corticosteroids in the plasma of newborn rabbits during the first hours of life (author's transl)].

Authors:  A Bichler; H Wiesinger; M Mayr
Journal:  Arch Gynecol       Date:  1978-12-29

7.  The role of glucocorticoid receptors in dexamethasone-induced apoptosis of neuroprogenitor cells in the hippocampus of rat pups.

Authors:  Chun-I Sze; Yung-Chieh Lin; Yuh-Jyh Lin; Ting-Hui Hsieh; Yu Min Kuo; Chyi-Her Lin
Journal:  Mediators Inflamm       Date:  2013-01-14       Impact factor: 4.711

8.  How do corticosteroids influence myelin genesis in the central nervous system?

Authors:  Divya M Chari
Journal:  Neural Regen Res       Date:  2014-05-01       Impact factor: 5.135
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.